US Stock MarketDetailed Quotes

MDCX Medicus Pharma

Watchlist

2.510
0.0000.00%

Close Jan 3 16:00 ET

29.66MMarket Cap-2.60P/E (TTM)

Medicus Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

1,225.21%3.01M

1,480.74%4.04M

342.82%1.78M

207.85%3.01M

1,079.95%2.13M

-16.42%226.81K

-1.27%255.69K

50.30%402.53K

-32.12%978.42K

180.27K

Selling and administrative expenses

1,081.17%2.2M

1,329.78%2.95M

331.91%1.44M

748.87%2.82M

2,208.60%2.09M

126.77%186.42K

182.34%206.12K

286.90%333.42K

28.69%332.03K

--90.64K

-General and administrative expense

1,081.17%2.2M

1,329.78%2.95M

331.91%1.44M

748.87%2.82M

2,208.60%2.09M

126.77%186.42K

182.34%206.12K

286.90%333.42K

28.69%332.03K

--90.64K

Research and development costs

1,824.78%777.51K

2,055.88%1.07M

357.78%316.39K

-70.05%193.58K

-61.51%34.5K

-78.64%40.4K

-73.34%49.58K

-61.95%69.11K

-45.38%646.38K

--89.63K

Depreciation amortization depletion

--26.32K

--26.04K

----

--0

----

-Depreciation and amortization

--26.32K

--26.04K

----

--0

----

Operating profit

-1,225.21%-3.01M

-1,480.74%-4.04M

-342.82%-1.78M

-207.85%-3.01M

-1,079.95%-2.13M

16.42%-226.81K

1.27%-255.69K

-50.30%-402.53K

32.12%-978.42K

-180.27K

Net non-operating interest income expense

115.18%46.53K

77.12%-88.26K

97.31%-9.01K

-6.21%-1.17M

-34.31%-431.59K

-9.30%-306.48K

-41.64%-385.79K

-46.63%-334.56K

-59.55%-1.1M

-321.33K

Non-operating interest income

--55.51K

----

--0

----

Non-operating interest expense

-97.07%8.98K

-63.52%88.26K

-95.28%9.01K

40.29%739.1K

--0

124.45%306.48K

88.26%241.92K

126.20%190.7K

356.50%526.83K

--177.47K

Total other finance cost

----

-25.00%431.59K

----

-0.00%143.86K

0.00%143.86K

0.00%575.45K

--143.86K

Other net income (expense)

-769.93%-2.6M

-261.22%-289.21K

-1,582.18%-2.43M

1,301.82%152.81K

339.09%253.17K

404.44%388.31K

179.39K

Gain on sale of security

----

427.53%670.1K

204.37%431.59K

-26.66%120.26K

1,301.82%152.81K

339.09%253.17K

-365.78%-204.6K

---413.51K

Special income (charges)

----

--0

----

--592.9K

----

-Less:Other special charges

----

---592.9K

----

Other non- operating income (expenses)

----

---3.27M

---720.8K

---2.55M

----

Income before tax

0.15%-2.96M

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

Income tax

Net income

0.15%-2.96M

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

Net income continuous Operations

0.15%-2.96M

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

---322.21K

Minority interest income

Net income attributable to the parent company

0.15%-2.96M

-745.19%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

0.15%-2.96M

-745.19%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

Basic earnings per share

78.91%-0.31

-723.55%-0.5

-265.92%-0.22

-121.27%-1.94

-121.00%-0.3526

-665.54%-1.47

10.18%-0.0607

72.30%-0.0601

-243.36%-0.8768

-0.1596

Diluted earnings per share

78.91%-0.31

-723.55%-0.5

-265.92%-0.22

-121.27%-1.94

-121.00%-0.3526

-665.54%-1.47

10.18%-0.0607

72.30%-0.0601

-243.36%-0.8768

-0.1596

Dividend per share

Currency Unit

USD

Audit Opinions

Unaudited

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	1,225.21%3.01M	1,480.74%4.04M	342.82%1.78M	207.85%3.01M	1,079.95%2.13M	-16.42%226.81K	-1.27%255.69K	50.30%402.53K	-32.12%978.42K	180.27K
Selling and administrative expenses	1,081.17%2.2M	1,329.78%2.95M	331.91%1.44M	748.87%2.82M	2,208.60%2.09M	126.77%186.42K	182.34%206.12K	286.90%333.42K	28.69%332.03K	--90.64K
-General and administrative expense	1,081.17%2.2M	1,329.78%2.95M	331.91%1.44M	748.87%2.82M	2,208.60%2.09M	126.77%186.42K	182.34%206.12K	286.90%333.42K	28.69%332.03K	--90.64K
Research and development costs	1,824.78%777.51K	2,055.88%1.07M	357.78%316.39K	-70.05%193.58K	-61.51%34.5K	-78.64%40.4K	-73.34%49.58K	-61.95%69.11K	-45.38%646.38K	--89.63K
Depreciation amortization depletion	--26.32K	--26.04K	--26.04K	----	----	--0	--0	--0	----	----
-Depreciation and amortization	--26.32K	--26.04K	--26.04K	----	----	--0	--0	--0	----	----
Operating profit	-1,225.21%-3.01M	-1,480.74%-4.04M	-342.82%-1.78M	-207.85%-3.01M	-1,079.95%-2.13M	16.42%-226.81K	1.27%-255.69K	-50.30%-402.53K	32.12%-978.42K	-180.27K
Net non-operating interest income expense	115.18%46.53K	77.12%-88.26K	97.31%-9.01K	-6.21%-1.17M	-34.31%-431.59K	-9.30%-306.48K	-41.64%-385.79K	-46.63%-334.56K	-59.55%-1.1M	-321.33K
Non-operating interest income	--55.51K	----	----	----	----	--0	----	----	----	----
Non-operating interest expense	-97.07%8.98K	-63.52%88.26K	-95.28%9.01K	40.29%739.1K	--0	124.45%306.48K	88.26%241.92K	126.20%190.7K	356.50%526.83K	--177.47K
Total other finance cost	----	----	----	-25.00%431.59K	----	----	-0.00%143.86K	0.00%143.86K	0.00%575.45K	--143.86K
Other net income (expense)				-769.93%-2.6M	-261.22%-289.21K	-1,582.18%-2.43M	1,301.82%152.81K	339.09%253.17K	404.44%388.31K	179.39K
Gain on sale of security	----	----	----	427.53%670.1K	204.37%431.59K	-26.66%120.26K	1,301.82%152.81K	339.09%253.17K	-365.78%-204.6K	---413.51K
Special income (charges)	----	----	----	--0	----	----	----	----	--592.9K	----
-Less:Other special charges	----	----	----	----	----	----	----	----	---592.9K	----
Other non- operating income (expenses)	----	----	----	---3.27M	---720.8K	---2.55M	----	----	----	----
Income before tax	0.15%-2.96M	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K
Income tax
Net income	0.15%-2.96M	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K
Net income continuous Operations	0.15%-2.96M	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	---322.21K
Minority interest income
Net income attributable to the parent company	0.15%-2.96M	-745.19%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	0.15%-2.96M	-745.19%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K
Basic earnings per share	78.91%-0.31	-723.55%-0.5	-265.92%-0.22	-121.27%-1.94	-121.00%-0.3526	-665.54%-1.47	10.18%-0.0607	72.30%-0.0601	-243.36%-0.8768	-0.1596
Diluted earnings per share	78.91%-0.31	-723.55%-0.5	-265.92%-0.22	-121.27%-1.94	-121.00%-0.3526	-665.54%-1.47	10.18%-0.0607	72.30%-0.0601	-243.36%-0.8768	-0.1596
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unaudited	--	--	--	--	--	--

Heat List

Overall

No Data